The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain
Open accessAbstract
Genetic evidence suggests a role for apolipoprotein E (apoE) in Alzheimer's disease (AD) amyloidogenesis. Here, amyloid-associated apoE from 32 AD patients was purified and characterized. We found that brain amyloid-associated apoE apparently exists not as free molecules but as complexes with polymers of the amyloid beta peptide (A beta). Brain A beta-apoE complexes were detected irrespective of the apoE genotype, and similar complexes could be mimicked in vitro. The fine structure of purified A beta-apoE complexes was fibrillar, and immunogold labeling revealed apoE immunoreactivity along the fibrils. Thus, we conclude that A beta-apoE complexes are principal components of AD-associated brain amyloid and that the data presented here support a role for apoE in the pathogenesis of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Rapid induction of Alzheimer A beta amyloid formation by zinc
Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R. (1994) · Science · doi:10.1126/science.8073293 · Cited by 1,522
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Ma, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871
Apolipoprotein E: Structure-Function Relationships
Weisgraber, K. H. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60642-7 · Cited by 830
Research works printed but not linked: 27
- Abraham, 1988, Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimers disease, Cell, 52, 487, 10.1016/0092-8674(88)90462-X · DOI · Paper page
- Berr, 1994, Apolipoprotein E allele ε4 is linked to increased deposition of the amyloid β-peptide (A-β) in cases with or without Alzheimer's disease, Neurosci. Lett., 178, 221, 10.1016/0304-3940(94)90763-3 · DOI
- Cardin, 1986, Binding of a high reactive heparin to human apolipoprotein E: identification of two heparin-binding domains, Biochem. Biophys. Res. Commun., 134, 783, 10.1016/S0006-291X(86)80489-2 · DOI
- Coria, 1988, Isolation and characterization of amyloid P component from Alzheimers disease and other types of cerebral amyloidosis, Lab. Invest., 58, 454
- Davies, 1993, Is the “preamyloid” of diffuse plaques in Alzheimer's disease really nonfibrillar?, Am. J. Pathol., 143, 1594
- Glenner, 1980, Amyloid deposits and amyloidosis: the β-fibrilloses (first of two parts), J. Engl. J. Med., 302, 1283, 10.1056/NEJM198006053022305 · DOI · Paper page
- Glenner, 1984, Alzheimers disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem. Biophys. Res. Commun., 120, 885, 10.1016/S0006-291X(84)80190-4 · DOI · Paper page
- Heukeshoven, 1985, Characterization of a solvent system for separation of water-insoluble Poliovirus proteins by reversed-phase high-performance liquid chromatography, J. Chromatogr., 326, 91, 10.1016/S0021-9673(01)87434-3 · DOI
- Jarret, 1993, Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?, Cell, 73, 1055, 10.1016/0092-8674(93)90635-4 · DOI · Paper page
- Kida, 1994, Regional differences in apolipoprotein E immunoreactivity in diffuse plaques in Alzheimer's disease brain, Neurosci. Lett., 167, 73, 10.1016/0304-3940(94)91030-8 · DOI
- Kim, 1988, Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide, Neurosci. Res. Commun., 2, 121
- Kim, 1990, Detection and quantitation of amyloid β-peptide with two monoclonal antibodies, Neurosci. Res. Commun., 7, 113
- Mayeux, 1993, The apolipoprotein E epsilon 4 allele in patients with Alzheimer's disease, Ann. Neurol., 34, 752, 10.1002/ana.410340527 · DOI · Paper page
- McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
- Milne, 1981, Characterization of monoclonal antibodies against human apolipoprotein E, J. Clin. Invest, 68, 111, 10.1172/JCI110225 · DOI
- Namba, 1991, Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease, Brain. Res., 541, 163, 10.1016/0006-8993(91)91092-F · DOI · Paper page
- Nordstedt, 1994, The Alzheimer Aβ peptide develops protease resistance in association with its polymerization into fibrils, J. Biol. Chem., 269, 30773, 10.1016/S0021-9258(18)47347-4 · DOI
- Peacock, 1994, ApoE ε4 allelic association with Alzheimer's disease: independent confirmation using denaturing gradient gel electrophoresis, Neurology, 44, 339, 10.1212/WNL.44.2.339 · DOI
- Rebeck, 1993, Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions, Neuron, 11, 575, 10.1016/0896-6273(93)90070-8 · DOI · Paper page
- Rozemuller, 1989, A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition, J. Neuropathol. Exp. Neurol., 48, 674, 10.1097/00005072-198911000-00009 · DOI · Paper page
- Selkoe, 1991, The molecular pathology of Alzheimeis disease, Neuron, 6, 487, 10.1016/0896-6273(91)90052-2 · DOI · Paper page
- Snow, 1990, Early accumulation of heparin sulfate in neurons and in the β-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome, Am. J. Pathol., 137, 1253
- Weisgraber, 1983, The receptor-binding domain of human apolipoprotein E, J. Biol. Chem., 258, 12348, 10.1016/S0021-9258(17)44181-0 · DOI · Paper page
- Wenham, 1991, Apolipoprotein E genotyping by one-stage PCR, Lancet, 337, 1158, 10.1016/0140-6736(91)92823-K · DOI · Paper page
- Wisniewski, 1992, Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid, Neurosci. Lett., 135, 235, 10.1016/0304-3940(92)90444-C · DOI · Paper page
- Wisniewski, 1994, Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro, Am. J. Pathol., 145, 1030
- Wunderlich, 1992, Use of recombinant fusion proteins for generation and rapid characterization of monoclonal antibodies. Application to the Kunitz domain of human R amyloid precursor protein, J. Immunol. Meth., 147, 1, 10.1016/S0022-1759(12)80022-6 · DOI
Cited by
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661
Mechanisms of Neuronal Degeneration in Alzheimer's Disease
Yankner, B. A. (1996) · Neuron · doi:10.1016/s0896-6273(00)80115-4 · Cited by 955
Alzheimer’s disease: the cholesterol connection
Puglielli, L., Tanzi, R. E., & Kovacs, D. M. (2003) · Nature Neuroscience · doi:10.1038/nn0403-345 · Cited by 677
Statins for the prevention of dementia
McGuinness, B., Craig, D., Bullock, R., & Passmore, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160.pub3 · Cited by 490
Bales, K. R., Verina, T., Cummins, D. J., Du, Y., Dodel, R. C., Saura, J., Fishman, C. E., DeLong, C. A., Piccardo, P., Petegnief, V., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15233 · Cited by 486
Metadata
- Authors
- Näslund, J., Thyberg, J., Tjernberg, L. O., Wernstedt, C., Karlström, A. R., Bogdanovic, N., Gandy, S. E., Lannfelt, L., Terenius, L., & Nordstedt, C.
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 1995-07
- Volume
- 15
- Issue
- 1
- Pages
- 219-228
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2048509804
- Cited by
- 189
- References
- 17
- FWCI
- 8.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 3081 d)
- Funders
- Svenska Sällskapet för Medicinsk Forskning
- Starr Foundation
- National Institutes of Health (HL49571-01, AG-11506)
- Medicinska Forskningsrådet
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain. https://app.cochat.ai/papers/10.1016/0896-6273(95)90079-9
- The paper
- Näslund, J., Thyberg, J., Tjernberg, L. O., Wernstedt, C., Karlström, A. R., Bogdanovic, N., Gandy, S. E., Lannfelt, L., Terenius, L., & Nordstedt, C. (1995). Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain. Neuron. https://doi.org/10.1016/0896-6273(95)90079-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.